EnduRx Pharmaceuticals produces a drug that targets proteins expressed on the surface of cells in the microenvironment of solid tumors. 2020 – awarded $1.4M DOD grant
EnduRx Pharmaceuticals produces a drug that targets proteins expressed on the surface of cells in the microenvironment of solid tumors. 2020 – awarded $1.4M DOD grant